230 likes | 353 Views
Chemical Addictions — General Overview. Abdullahi Mubarak, MD Medical Director of Addiction Services at PEMCO Chief Medical Officer at Consortium Clinical Services, LLC. Objectives. Understand general terminology The disease of Addiction Symptoms of the disease Stages of change
E N D
Chemical Addictions—General Overview Abdullahi Mubarak, MD Medical Director of Addiction Services at PEMCO Chief Medical Officer at Consortium Clinical Services, LLC
Objectives • Understand general terminology • The disease of Addiction • Symptoms of the disease • Stages of change • Diagnostic tips • General treatment approaches
Terminology • Use—drug taking not associated with harm • Abuse—drug taking associated with harm • Dependence—adaptation to drug evidenced by normal functioning and/or withdrawal syndrome • Addiction—loss of control, compulsion, continued use despite adverse consequences
Terminology • Abuse potential—the likelihood that a person will abuse a drug based upon it’s pleasurable effects, toxicity, and society’s attitude toward the users of the drug • Addiction potential—the likelihood that a drug will produce addiction in chronic users
Relative Addiction Potential • Cocaine (crack, IV, snorted, chewed) • Methamphetamine (smoked) • Nicotine (IV, smoked, chewed) • Opiates (IV, smoked, snorted, chewed, oral) • Alcohol • Sedative-hypnotics • Anabolic steroids • Marijuana • Inhalants • PCP, other hallucinogens (LSD, Special K, )
Disease of Addiction • Addiction is primarily a function of many genetically predisposed biological responses. • The response and/or lack of the drug reinforces the repeated use of the drug. • The environment permits and facilitates the use of the drug. • Addiction can be “created” in low risk patients with chronic use of drugs of high addictive potential.
Progression of the Disease • Erratic drug-taking pattern, erratic sleep, work, eating, grooming, and social habits • New forms of enjoyment, new “friends”, ways of relating, isolation, hiding money, hiding whereabouts, lying • Legal, financial, marital, social, career, and lastly physical adverse consequences
Stages of Change • Pre-contemplation—lacks awareness • Contemplation—ambivalent about change • Preparation—getting information in order to change • Action—actually committing to sobriety in deed • Maintenance—attaining stability • Recovery—sobriety • Relapse—use leads to return to contemplation
Signs of Aberrant behavior • Prescription forgery • Concurrent abuse of illicit drugs • Selling prescriptions • Recurrent lost, stolen, or spilled drugs • Stealing or borrowing from others • Obtaining drugs from non-medical sources • Obtaining scripts from multiple doctors
Indicators of Suspicion • Reluctant to present identification • “Out of town” patient • Overly willing to pay cash • Telephone call in for controlled substances • Presents when the regular physician cannot be reached
Indicators of Suspicion • Allergy to NSAIDS, COX-2’s, or codeine • Intolerant to collateral contacts • Intolerant to in-depth interviews • Interested only in the drug, not the diagnosis • Reluctant to comply with diagnostic testing, pill counts, and urine screening
Factors Less Indicative • Drug hoarding during periods of decreased symptoms • Unsanctioned dose escalation • Request for specific drugs by name • Focus on opiate issues during the first three office visits
Abnormal Physical Signs • Pupils < 3mm or >6.5mm in room light • Presence of nystagmus • Diminished or absent corneal and/or pupillary light reflex • Impaired convergence • Pulse < 60 or > 100/min • Venosclerosis or needle tracks • Perforated nasal septum
Characteristics of the Painpatient • Appreciates in-depth interviews • Cooperates with attempts to get collateral histories • Cooperates with pill counts and urine drug screening • Focus is on the diagnosis and the cure • Attempts to reduce medications on their own • Cooperates with diagnostic and therapeutic interventions
Addressing Aberrancy and indicators of suspicion • Obtain an INSPECT report • Urine drug screen (UDS) • Use oral salivary testing when urine screening is unavailable, patient unable to void, or the UDS is invalid • Pill counts when appropriate • Use Axis V outline to clarify your thoughts • Treat ONLY according to your diagnosis
INSPECT reports • The report is unconfirmed history until you confirm what’s in it. • “Multiple prescribers” means nothing until you call the providers to find out what they did, why they did it, and did they know there were other prescribers • Keep the interpretation of the report in your chart
Urine drug screening • The results only mean what the results say • Using them to make a diagnosis is only part of the total picture • Refer for addiction consultation, if the results are aberrant • Negative screens can mean abuse, addiction, diversion, or pseudo-addiction syndrome • Do not collect without temperature strips on the cup. • Be sure the reference lab tests for validity and multiple metabolites
Oral Salivary Testing • Easy to use, less intrusive • Shorter window of detection compared to urine drug screening • Accuracy comparable to blood testing • The results only mean what the result says
Pill Counts • Best when used sparingly or unexpected • Best to clarify negative urine drug screens • Order within 2 days to rule out diversion • Order within 10 days to rule out abuse or addiction • Pills can be brought to office or the pharmacy they purchased their pills • Record any markings on the pills for identification
Diagnostic Challenges • Impaired by lack of knowledge of differential diagnosis • Impaired by EMOTIONAL reactions to the “names” of controlled substances • Use Axis V outline to highlight deficiencies in knowledge or when you are becoming too emotional • Say “NO”, if the request is inappropriate for the diagnosis or you have inadequate information to arrive at a diagnosis • Continue to monitor to confirm or deny your provisional diagnosis. Being wrong is ok.
Consultation • Learn the biases of your consultants. • Psychiatry consultation for benzo and stimulant prescribing for mood disorders, ADHD, etc… • Addiction consultation to evaluate aberrancy • Pain management consultation to evaluate opiate prescribing
General treatment principles • Foremost goal initially is self-diagnosis • Educate—Addiction is a disorder in a person, not the pill • Medication assistance—diminish drug craving, withdrawal, and normalize function • Intensity of treatment related to intensity of use pattern and/or history of treatment failures • Strengthen social/spiritual supports